SOLVE THE IMPOSSIBLE
LIVE

Serial Number

90046934

Owner

Medidata Solutions, Inc.

Attorney

Jordan A LaVine

First Use Date

Oct 20, 2020

Filing Date

Jul 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SOLVE THE IMPOSSIBLE Trademark

Serial Number: 90046934 • Registration: 6350131

SOLVE THE IMPOSSIBLE is a trademark filed by Medidata Solutions, Inc. on July 10, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Medidata Solutions, Inc. (2 trademarks)

350 Hudson Street
New York, NY 10014

Entity Type: 03

Trademark Details

Filing Date

July 10, 2020

Registration Date

May 11, 2021

First Use Anywhere

October 20, 2020

First Use in Commerce

October 20, 2020

Published for Opposition

December 1, 2020

Goods & Services

Providing medical and scientific data analytics analysis and providing a website featuring non-downloadable software using artificial intelligence for analyzing, monitoring, and formatting scientific data in the life sciences field for the purpose of research, development and commercialization; Development and implementation of new technology solutions for others in the life sciences field for the purpose of research, development and commercialization; Technical consulting related to data analytics and artificial intelligence technology solutions in the life sciences field; Software as a service (SAAS) services featuring software for managing, gathering, organizing, and sharing data, information and images in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; Providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of medical clinical trials; Providing an on-line searchable database in the fields of medical clinical trials and medical research; Medical research; Research and development and consultation related thereto in the field of clinical trials; compiling data for medical and scientific research and analytical purposes in the field of clinical trials, medical science and medical consultancy

Analysis of business data in the life sciences field for the purpose of research, development and commercialization

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 11, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
May 11, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 7, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 6, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 21, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 21, 2021 AITU
USE AMENDMENT FILED
Mar 2, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 2, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 26, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 21, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2020 NWOS
NEW APPLICATION ENTERED
Jul 14, 2020 NWAP